drugset
drugset / Trial / NCT04230252

A Study of the Newly Formulated Tylenol Tablet (Acetaminophen) to the Tylenol 8 Hour (H) Extended Release (ER) Tablet (Acetaminophen) in Healthy Participants

NCT04230252 ↗

Phase 1 Completed 30 enrolled Janssen Korea, Ltd., Korea
RandomizedCrossoverOpen-labelOther

Summary

The purpose of this study is to evaluate the bioequivalence of the newly formulated Tylenol tablet (acetaminophen 650 mg) with respect to the Tylenol 8 Hour (H) Extended Release (ER) tablet (acetaminophen 650 mg) in healthy participants under fasting conditions.

Timeline

Start
2020-01-07
Primary completion
2020-02-10
Completion
2020-03-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 650 mg Oral

Indications

No indication recorded.